Abstract:Background: Allergic asthma is a chronic bronchial inflammatory disease closely associated with abnormal immune responses of dendritic cells (DCs) and allergen-specific type 2 T helper (Th2) cells. Indirubin (IR), a natural aryl hydrocarbon receptor (AhR) ligand, exerts anti-inflammatory and immunomodulatory properties. Purpose: In this study, we aimed to clarify whether IR exhibits immunomodulatory action on DCs via AhR activation and investigated the antiallergic effects of IR in a mouse model of allergic asthma. Methods: Lipopolysaccharide (LPS)-activated bone marrow-derived DCs were treated with IR. Their mRNA expressions, cytokine production, and phenotype patterns were determined by a quantitative real-time PCR, ELISA, flow cytometry, and RNA sequencing. The mixed lymphocyte reaction was utilized to evaluate the regulatory function of IR-treated DCs on T-cell differentiation. Moreover, mice with ovalbumin (OVA)-induced allergic asthma were treated with IR. Thereafter, the airway hyperresponsiveness (AHR), allergen-specific IgE production, cytokine levels, airway inflammation, and T-cell responses were evaluated. Results: Treatment of LPS-stimulated DCs with 20 μM IR significantly reduced IL-12 and TNF-α production while increasing IL-10 secretion. Meanwhile, these DCs expressed decreased levels of CD80 but increased levels of Jagged 1 surface molecules. However, the effects of IR on DCs were reversed by pretreatment with the AhR antagonist, CH223191. Additionally, the coculture of these tolerogenic-like DCs with allogeneic CD4 + T cells promoted the generation of Foxp3 + regulatory T (Treg) cells. A transcriptomic analysis identified several downregulated genes that are involved in regulating cell migration, cytokine secretion, and inflammatory responses in DCs after IR treatment. In an asthmatic murine model, oral administration of 25 mg/kg body weight of IR efficiently alleviated the development of AHR, OVA-specific IgE production, and levels of Th2-type cytokines (IL-4, IL-5, and IL-13) and the CCL11 chemokine. IR treatment also attenuated inflammatory cell recruitment and mucus production in the lungs. Notably, an enhanced frequency of Foxp3 + Treg cells and reduced effector T-cell proliferation associated with increased levels of IL-10 and TGF-β were observed in IR-treated mice. Conclusion: IR can induce tolerogenic-like BMDCs which promote the differentiation of Treg cells. Importantly, the expansion of Foxp3 + Treg cells contributed to the therapeutic efficacy of IR against allergic asthma.

Bilirubin Represents a Negative Regulator of ILC2 in Allergic Airway Inflammation

Bilirubin Inhibits NLRP3 Inflammasome Activation by Maintaining the Stability of Mitochondria Membranes

Physiological concentrations of bilirubin control inflammatory response by inhibiting NF-B and inflammasome activation

IL-27 Signaling Negatively Regulates FcɛRI-mediated Mast Cell Activation and Allergic Response

The ketone body β-hydroxybutyrate mitigates ILC2-driven airway inflammation by regulating mast cell function

Iron controls the development of airway hyperreactivity by regulating ILC2 metabolism and effector function

Blocking CD226 regulates ILC2 effector function and alleviates airway hyperreactivity

Use of the Informatics for Integrating Biology and the Bedside (i2b2) Population to Test Serum Bilirubin Levels and Risk for Inflammatory Bowl Diseases and the Involvement of Uridine Glucuronosyltransferase Genes

Indirubin induces tolerogenic dendritic cells via aryl hydrocarbon receptor activation and ameliorates allergic asthma in a murine model by expanding Foxp3-expressing regulatory T cells

Bilirubin as a signaling molecule

The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms

Interferons as negative regulators of ILC2s in allergic lung inflammation and respiratory viral infections

E3 Ubiquitin Ligase Cbl-b Inhibits Type 2 Innate Lymphoid Cell Development by Targeting ST2 for Ubiquitination

Alarmin-loaded extracellular lipid droplets induce airway neutrophil infiltration during type 2 inflammation

Unconjugated Bilirubin Attenuates DSS-Induced Colitis Potentially <i>via</i> Enhancement of Bilirubin Reabsorption

ICAM-1 Controls Development and Function of ILC2

ILC2s: Unraveling the Innate Immune Orchestrators in Allergic Inflammation

Bimin Kang ameliorates the minimal persistent inflammation in allergic rhinitis by reducing BCL11B expression and regulating ILC2 plasticity

SIRPα engagement regulates ILC2 effector function and alleviates airway hyperreactivity via modulating energy metabolism

IKKβ increases neuropilin-2 and promotes the inhibitory function of CD9+ Bregs to control allergic diseases

Type 2 innate lymphoid cells are protective against hepatic ischaemia/reperfusion injury